MONDAY, Aug. 12, 2024 (HealthDay News) — Advocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S. Food and Drug Administration declined to approve it as treatment for post-traumatic stress disorder (PTSD). There is insufficient evidenceContinue Reading

THURSDAY, Aug. 8, 2024 (HealthDay News) — That vape pen might contain something even worse than nicotine, new research warns. Tobacco companies may be trying to duck federal restrictions on vaping products by replacing nicotine with “nicotine analogs” — related chemicals that have similar properties but unknown health effects, researchersContinue Reading